[1]
A. Rabiega-Przyłęcka, “Model of Ethical Assessment of Clinical Trials of Medicinal Product after the Entry into Force of Regulation 536/2014 and the Protection of a Clinical Trial Participant – Remarks in the Light of the New Act on Clinical Trials of Medicinal Products for Hum”, FOI, pp. 269–280, Feb. 2024.